martes, 28 de octubre de 2025

Onshoring Drug Manufacturing: Insights from FDA’s PreCheck Initiative and Public Meeting October 28, 2025 By Mark I. Schwartz & Julie Kim —

https://www.thefdalawblog.com/2025/10/onshoring-drug-manufacturing-insights-from-fdas-precheck-initiative-and-public-meeting/?utm_source=rss&utm_medium=rss&utm_campaign=onshoring-drug-manufacturing-insights-from-fdas-precheck-initiative-and-public-meeting

No hay comentarios: